Copenhagen – The Stevanato Group is an international leader in the production of tubular injection vials for insulin and of glass containers for pharmaceutical use, as well as technology for the development of machinery to process glass tubes. The Italian group is strengthening its Engineering division through the acquisition of a 65% stake in the Danish SVM Automatik, specialized in equipment for the assembly, packaging and solutions for serialization. “Our group is active in two business segments: Pharmaceutical Systems and Engineering Systems, two segments that work closely together – explains Franco Stevanato, CEO of Stevanato Group. – Thanks to SVM Automatik know-how, we can further strengthen the skills of our engineering division in the design and construction of equipment for assembly and packaging in the pharmaceutical industry. We bought a 65% stake in the company with the option, exercisable in the next few years, to acquire the remaining 35% of capital.” (9Colonne)
